American Century Companies Inc. reduced its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 10.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,193 shares of the company's stock after selling 2,374 shares during the period. American Century Companies Inc.'s holdings in Molina Healthcare were worth $6,981,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC lifted its position in Molina Healthcare by 74,593.7% during the first quarter. GAMMA Investing LLC now owns 667,015 shares of the company's stock worth $219,708,000 after buying an additional 666,122 shares in the last quarter. Northern Trust Corp raised its position in Molina Healthcare by 14.9% in the fourth quarter. Northern Trust Corp now owns 607,601 shares of the company's stock valued at $176,842,000 after purchasing an additional 78,950 shares during the period. Jacobs Levy Equity Management Inc. raised its position in Molina Healthcare by 6.4% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 537,057 shares of the company's stock valued at $156,310,000 after purchasing an additional 32,273 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Molina Healthcare by 2.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 458,651 shares of the company's stock valued at $133,490,000 after purchasing an additional 11,960 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Molina Healthcare by 4.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 416,241 shares of the company's stock valued at $137,106,000 after buying an additional 16,161 shares during the period. Hedge funds and other institutional investors own 98.50% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on MOH shares. UBS Group cut their price objective on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $210.00 price objective on shares of Molina Healthcare in a research report on Tuesday, August 26th. Mizuho reduced their price objective on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Barclays reduced their price objective on Molina Healthcare from $270.00 to $186.00 and set an "equal weight" rating for the company in a research note on Friday, July 25th. Finally, JPMorgan Chase & Co. reduced their price objective on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research note on Tuesday, July 29th. Three investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $242.91.
View Our Latest Stock Analysis on MOH
Insiders Place Their Bets
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the business's stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO James Woys acquired 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The shares were bought at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the purchase, the chief operating officer owned 74,331 shares of the company's stock, valued at $11,591,176.14. This represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.26% of the stock is currently owned by company insiders.
Molina Healthcare Trading Up 3.5%
Shares of MOH stock traded up $6.15 during mid-day trading on Monday, hitting $180.87. 1,489,455 shares of the company's stock were exchanged, compared to its average volume of 1,498,875. Molina Healthcare, Inc has a fifty-two week low of $151.95 and a fifty-two week high of $365.23. The stock has a 50-day simple moving average of $199.34 and a two-hundred day simple moving average of $273.25. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.77. The stock has a market cap of $9.80 billion, a price-to-earnings ratio of 8.91 and a beta of 0.54.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. During the same quarter last year, the business earned $5.86 EPS. Molina Healthcare's revenue for the quarter was up 15.7% compared to the same quarter last year. Equities analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.